/Companies

Thestra

Turku, FI · 1 known investors

Find your way into Thestra

Sign up to see every warm intro you have to Thestra

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Thestra team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Thestra is a University of Turku spin-out developing AI-based cancer diagnostics, including its EPLINEX biomarker assay that estimates tumor aggressiveness in head and neck squamous cell carcinoma (HNSCC) to help clinicians stratify patients to appropriate therapies. Its products serve clinicians and hospitals to guide treatment selection and prognosis.

Founders & leadership

SVSami Ventelä
Sami VenteläCo-founder & Board Member
JWJukka Westermarck
Jukka WestermarckCo-founder & Board Member
JJJuuso Juhila
Juuso JuhilaCEOJuuso Juhila holds a PhD in biomedicine from the University of Helsinki and brings experience in diagnostic and pharmaceutical R&D, with expertise in bioinformatics, life sciences, and genetics. He is CEO of Thestra, a University of Turku spin-out developing AI-based cancer diagnostics for head and neck squamous cell carcinoma.
MJMatti Juvonen
Matti JuvonenChief Business OfficerMatti Juvonen has 15+ years of international sales and business development experience in life sciences and medical technologies, with prior roles at Vivago, Innomedica, Medix Biochemica, ThermoLabsystems, Business Finland, MariMatic, and IBM. He serves as Chief Business Officer of Thestra, a University of Turku spin-out developing AI-based cancer diagnostics for head and neck squamous cell carcinoma.

Investors · 1

Frequently asked questions

What does Thestra do?
Thestra is a University of Turku spin-out developing AI-based cancer diagnostics, including its EPLINEX biomarker assay that estimates tumor aggressiveness in head and neck squamous cell carcinoma (HNSCC) to help clinicians stratify patients to appropriate therapies. Its products serve clinicians and hospitals to guide treatment selection and prognosis.
Who founded Thestra?
Thestra was founded by Sami Ventelä, Jukka Westermarck.
Who are Thestra's investors?
Thestra's investors include Nordic Science Investments.
Where is Thestra headquartered?
Thestra is headquartered in Turku, FI.